E7080 Food Effect Study in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 12 Mar 2015
At a glance
- Drugs Lenvatinib (Primary)
- Indications Endometrial cancer; Liver cancer; Lymphoma; Malignant melanoma; Non-small cell lung cancer; Ovarian cancer; Renal cancer; Thyroid cancer
- Focus Pharmacokinetics
- Sponsors Eisai Inc
- 19 Feb 2014 Results published in the International Journal of Clinical Pharmacology and Therapeutics.
- 01 Nov 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 27 Apr 2011 Planned end date changed from Jan 2011 to Nov 2011 as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History